LOGIN  |  REGISTER
C4 Therapeutics

Recent Insider Transactions - Aclaris Therapeutics (NASDAQ: ACRS)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ACRS Aclaris Therapeutics
Walker Neal / director, officer: INTERIM CEO
12/04/2024
Buy
$1.52
118,840
$181K
1.50M
NASDAQ ACRS Aclaris Therapeutics
Walker Neal / director, officer: INTERIM CEO
12/04/2024
Sell
$3.76
68,343
$257K
1.43M
NASDAQ ACRS Aclaris Therapeutics
Walker Neal / director, officer: INTERIM CEO
12/04/2024
Sell
$1.52
118,840
$181K
0
NASDAQ ACRS Aclaris Therapeutics
Davis Hugh M. / director, officer: President and COO
12/02/2024
Buy
$3.96
375,000
$1.485M
375,000
NASDAQ ACRS Aclaris Therapeutics
Walker Neal / director, officer: INTERIM CEO
12/01/2024
Sell
$4.07
2,721
$11K
1.38M
NASDAQ ACRS Aclaris Therapeutics
Biosion, Inc. / 10 percent owner
11/18/2024
Sell
$0.0001
11.28M
$1K
0
NASDAQ ACRS Aclaris Therapeutics
Mehra Anand / director
11/19/2024
Buy
$2.25
666,666
$1.500M
710,030
NASDAQ ACRS Aclaris Therapeutics
Walker Neal / director, officer: INTERIM PRESIDENT AND CEO
11/01/2024
Sell
$2.09
2,721
$6K
1.38M

COPYRIGHT ©2023 HEALTH STOCKS HUB